PI(3,4,5)P3 interactome

Journal of Proteome Research

Volumn 8, Issue 7, 2009, Pages 3712-3726

  Catimel, Bruno ^a   Yin, Meng Xin ^b   Schieber, Christine ^b   Condron, Melanie ^a   Patsiouras, Heather ^a   Catimel, Jenny ^a   Robinson, Diane E J E ^b   Wong, Leon S M ^b   Nice, Edouard C ^a   Holmes, Andrew B ^b   Burgess, Antony W ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Interactome; Microaffinity purification; Phosphoinositides; Proteomics

Indexed keywords

BINDING PROTEIN; CELL EXTRACT; LIPOSOME; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE;

ARTICLE; BINDING AFFINITY; BINDING SITE; CLASSIFICATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTERACTOME; LIPOGENESIS; MOLECULAR INTERACTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; PURIFICATION; UNINDEXED SEQUENCE;

CARCINOMA; CELL LINE, TUMOR; COLONIC NEOPLASMS; COMPUTATIONAL BIOLOGY; CYTOSOL; GLUTATHIONE TRANSFERASE; HUMANS; LIPOSOMES; MASS SPECTROMETRY; MODELS, CHEMICAL; PHOSPHATES; PHOSPHATIDYLINOSITOL PHOSPHATES; PROTEIN INTERACTION MAPPING; PROTEOME; PROTEOMICS;

EID: 67650364319     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900320a     Document Type: Article

References (83)

1. Di Paolo, G.; De Camilli, P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006, 443 (7112), 651-657.
2. Berridge, M. J. Inositol trisphosphate and calcium signalling mechanisms. Biochim. Biophys. Acta 2008. doi:, 10.1016/j.bbamcr.2008.10.005.
3. Cantley, L. C. The phosphoinositide 3-kinase pathway. Science 2002, 296 (5573), 1655-1657.
4. Vanhaesebroeck, B.; Leevers, S. J.; Ahmadi, K.; Timms, J.; Katso, R.; Driscoll, P. C.; Woscholski, R.; Parker, P. J.; Waterfield, M. D. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 2001, 70, 535-602.
5. Rameh, L. E.; Rhee, S. G.; Spokes, K.; Kazlauskas, A.; Cantley, L. C.; Cantley, L. G. Phosphoinositide 3-kinase regulates phospholipase C gamma-mediated calcium signaling. J. Biol. Chem. 1998, 273 (37), 23750-23757.
6. Lemmon, M. A.; Ferguson, K. M. Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem. J. 2000, 350 (1), 1-18.
7. Varnai, P.; Bondeva, T.; Tamas, P.; Toth, B.; Buday, L.; Hunyady, L.; Balla, T. Selective cellular effects of overexpressed pleckstrin-homology domains that recognize PtdIns(3,4,5)P-3 suggest their interaction with protein binding partners. J. Cell Sci. 2005, 118 (20), 4879-4888.
8. Rebecchi, M. J.; Scarlata, S. Pleckstrin homology domains: A common fold with diverse functions. Annu. Rev. Biophys. Biomol. Struct. 1998, 27, 503-528.
9. Ferguson, K. M.; Kavran, J. M.; Sankaran, V. G.; Fournier, E.; Isakoff, S. J.; Skolnik, E. Y.; Lemmon, M. A. Structural basis for discrimination of 3-phosphoinositides by pleckstrin homology domains. Mol. Cell 2000, 6 (2), 373-384.
10. Balla, T. Inositol-lipid binding motifs: signal integrators through protein-lipid and protein-protein interactions. J. Cell Sci. 2005, 118 (10), 2093-2104.
11. Lemmon, M. A. Phosphoinositide recognition domains. Traffic 2003, 4 (4), 201-213.
12. Overduin, M.; Cheever, M. L.; Kutateladze, T. G. Signaling with phosphoinositides: better than binary. Mol. Interv. 2001, 1 (3), 150-159.
13. Kutateladze, T.; Overduin, M. Structural mechanism of endosome docking by the FYVE domain. Science 2001, 291 (5509), 1793-1796.
14. Lemmon, M. A.; Ferguson, K. M. Molecular determinants in pleckstrin homology domains that allow specific recognition of phosphoinositides. Biochem. Soc. Trans. 2001, 29 (4), 377-384.
15. Lemmon, M. A. Membrane recognition by phospholipid-binding domains. Nat. Rev. Mol. Cell Biol. 2008, 9 (2), 99-111.
16. Cantley, L. C.; Neel, B. G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. U.S.A. 1999, 96 (8), 4240-4245.
17. DiNitto, J. P.; Lambright, D. G. Membrane and juxtamembrane targeting by PH and PTB domains. Biochim. Biophys. Acta 2006, 1761 (8), 850-867.
18. Bottomley, M. J.; Salim, K.; Panayotou, G. Phospholipid-binding protein domains. Biochim. Biophys. Acta 1998, 1436 (1-2), 165-183.
19. Carlton, J. G.; Cullen, P. J. Coincidence detection in phosphoinositide signaling. Trends Cell Biol. 2005, 15 (10), 540-547.
20. Lemmon, M. A. Pleckstrin homology domains: not just for phosphoinositides. Biochem. Soc. Trans. 2004, 32 (5), 707-711.
21. Fruman, D. A.; Meyers, R. E.; Cantley, L. C. Phosphoinositide kinases. Annu. Rev. Biochem. 1998, 67, 481-507.
22. Foster, F. M.; Traer, C. J.; Abraham, S. M.; Fry, M. J. The phosphoinositide (PI) 3-kinase family. J. Cell Sci. 2003, 116 (15), 3037-3040.
23. Vivanco, I.; Sawyers, C. L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer 2002, 2 (7), 489-501.
24. Hawkins, P. T.; Anderson, K. E.; Davidson, K.; Stephens, L. R. Signalling through class I PI3Ks in mammalian cells. Biochem. Soc. Trans. 2006, 34 (5), 647-662.
25. Takenawa, T.; Itoh, T. Membrane targeting and remodeling through phosphoinositide-binding domains. IUBMB Life 2006, 58 (5-6), 296-303.
26. Du, K. Y.; Tsichlis, P. N. Regulation of the Akt kinase by interacting proteins. Oncogene 2005, 24 (50), 7401-7409.
27. Hennessy, B. T.; Smith, D. L.; Ram, P. T.; Lu, Y. L.; Mills, G. B. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov. 2005, 4 (12), 988-1004.
28. Martin, T. F. J. Phosphoinositide lipids as signaling molecules: Common themes for signal transduction, cytoskeletal regulation, and membrane trafficking. Annu. Rev. Cell. Dev. Biol. 1998, 14, 231-264.
29. Alessi, D. R.; Andjelkovic, M.; Caudwell, B.; Cron, P.; Morrice, N.; Cohen, P.; Hemmings, B. A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996, 15 (23), 6541-6551.
30. Hemmings, B. A. Signal transduction - Akt signaling: Linking membrane events to life and death decisions. Science 1997, 275 (5300), 628-630.
31. Mora, A.; Komander, D.; van Aalten, D. M.; Alessi, D. R. PDK1, the master regulator of AGC kinase signal transduction. Semin. Cell Dev. Biol. 2004, 15 (2), 161-170.
32. Pendaries, C.; Tronchere, H.; Plantavid, M.; Payrastre, B. Phosphoinositide signaling disorders in human diseases. FEBS Lett. 2003, 546 (1), 25-31.
33. Vicinanza, M.; D'Angelo, G.; Di Campli, A.; De Matteis, M. A. Phosphoinositides as regulators of membrane trafficking in health and disease. Cell. Mol. Life Sci. 2008, 65 (18), 2833-2841.
34. Prestwich, G. D. Phosphoinositide signaling; From affinity probes to pharmaceutical targets. Chem. Biol. 2004, 11 (5), 619-637.
35. Yuan, T. L.; Cantley, L. C. PI3K pathway alterations in cancer: variations on a theme. Oncogene 2008, 27 (41), 5497-5510.
36. Bader, A. G.; Kang, S. Y.; Vogt, P. K. Cancer-specific mutations in PIK3CA are oncogenic in vivo. Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (5), 1475-1479.
37. Shayesteh, L.; Lu, Y. L.; Kuo, W. L.; Baldocchi, R.; Godfrey, T.; Collins, C.; Pinkel, D.; Powell, B.; Mills, G. B.; Gray, J. W. PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet. 1999, 21 (1), 99-102.
38. Parsons, D. W.; Wang, T.-L.; Samuels, Y.; Bardelli, A.; Cummins, J. M.; DeLong, L.; Silliman, N.; Ptak, J.; Szabo, S.; Willson, J. K. V.; Markowitz, S.; Kinzler, K. W.; Vogelstein, B.; Lengauer, C.; Velculescu, V. E. Colorectal cancer - Mutations in a signalling pathway. Nature 2005, 436 (7052), 792.
39. Klippel, A.; Escobedo, M. A.; Wachowicz, M. S.; Apell, G.; Brown, T. W.; Giedlin, M. A.; Kavanaugh, W. M.; Williams, L. T. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol. Cell. Biol. 1998, 18 (10), 5699-5711.
40. Franke, T. F.; Kaplan, D. R.; Cantley, L. C. PI3K: downstream AKTion blocks apoptosis. Cell 1997, 88 (4), 435-437.
41. Leslie, N. R.; Batty, I. H.; Maccario, H.; Davidson, L.; Downes, C. P. Understanding PTEN regulation: PIP2, polarity and protein stability. Oncogene 2008, 27 (41), 5464-5476.
42. Carracedo, A.; Pandolfi, P. P. The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene 2008, 27 (41), 5527-5541.
43. Catimel, B.; Schieber, C.; Condron, M.; Patsiouras, H.; Connolly, L.; Catimel, J.; Nice, E. C.; Burgess, A. W.; Holmes, A. B. The PI(3,5)P2 and PI(4,5)P2 Interactomes. J. Proteome Res. 2008, 7 (12), 5295-5313.
44. Krugmann, S.; Anderson, K. E.; Ridley, S. H.; Risso, N.; McGregor, A.; Coadwell, J.; Davidson, K.; Eguinoa, A.; Ellson, C. D.; Lipp, P.; Manifava, M.; Ktistakis, N.; Painter, G.; Thuring, J. W.; Cooper, M. A.; Lim, Z.-Y.; Holmes, A. B.; Dove, S. K.; Michell, R. H.; Grewal, A.; Nazarian, A.; Erdjument-Bromage, H.; Tempst, P.; Stephens, L. R.; Hawkins, P. T. Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol. Cell 2002, 9 (1), 95-108.
45. Pasquali, C.; Bertschy-Meier, D.; Chabert, C.; Curchod, M. L.; Arod, C.; Booth, R.; Mechtler, K.; Vilbois, F.; Xenarios, I.; Ferguson, C. G.; Prestwich, G. D.; Camps, M.; Rommel, C. A chemical proteomics approach to phosphatidylinositol 3-kinase signaling in macrophages. Mol. Cell. Proteomics 2007, 6 (11), 1829-1841.
46. Bauer, A.; Kuster, B. Affinity purification-mass spectrometry - Powerful tools for the characterization of protein complexes. Eur. J. Biochem. 2003, 270 (4), 570-578.
47. Catimel, B.; Rothacker, J.; Catimel, J.; Faux, M.; Ross, J.; Connolly, L.; Clippingdale, A.; Burgess, A. W.; Nice, E. Biosensor-based microaffinity purification for the proteomic analysis of protein complexes. J. Proteome Res. 2005, 4 (5), 1646-1656.
48. Whitehead, R. H.; Macrae, F. A.; St John, D. J.; Ma, J. A colon cancer cell line (LIM1215) derived from a patient with inherited non-polyposis colorectal cancer. J. Natl. Cancer Inst. 1985, 74 (4), 759-765.
49. Lim, Z. Y.; Thuring, J. W.; Holmes, A. B.; Manifava, M.; Ktistakis, N. T. Synthesis and biological evaluation of a PtdIns(4,5)P2 and a phosphatidic acid affinity matrix. J. Chem. Soc., Perkin Trans. 1 2002, (8), 1067-1075.
50. Stephens, L.; Hawkins, P. T.; Holmes, A. B.; Manifava, M.; Ktistakis, N.; Thuring, J. W. J. F. Methods of synthesis and uses for immobilized phosphatidic acid probes. WO 2002018946 A2. Chem. Abstr. 2002, 136, 229062.
51. Painter, G. F.; Thuring, J. W.; Lim, Z.-Y.; Holmes, A. B.; Hawkins, P. T.; Stephens, L. R. Synthesis and biological evaluation of a PtdIns(3,4,5)P3 affinity matrix. Chem. Commun. 2001, (7), 645-646.
52. Moritz, R. L.; Eddes, J. S.; Reid, G. E.; Simpson, R. J. S-pyridylethylation of intact polyacrylamide gels and in situ digestion of electrophoretically separated proteins: A rapid mass spectrometric method for identifying cysteine-containing peptides. Electrophoresis 1996, 17 (5), 907-917.
53. Simpson, R. J.; Connolly, L. M.; Eddes, J. S.; Pereira, J. J.; Moritz, R. L.; Reid, G. E. Proteomic analysis of the human colon carcinoma cell line (LIM 1215): development of a membrane protein database. Electrophoresis 2000, 21 (9), 1707-1732.
54. Browman, D. T.; Hoegg, M. B.; Robbins, S. M. The SPFH domain-containing proteins: more than lipid raft markers. Trends Cell Biol. 2007, 17 (8), 394-402.
55. Hediger, M. A.; Romero, M. F.; Peng, J. B.; Rolfs, A.; Takanaga, H.; Bruford, E. A. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins - Introduction. Pflugers Arch. - Eur. J. Physiol. 2004, 447 (5), 465-468.
56. Jackson, T. R.; Kearns, B. G.; Theibert, A. B. Cytohesins and centaurins: mediators of PI 3-kinase-regulated Arf signaling. Trends Biochem. Sci. 2000, 25 (10), 489-495.
57. Gillingham, A. K.; Munro, S. The small G proteins of the Arf family and their regulators. Annu. Rev. Cell. Dev. Biol. 2007, 23, 579-611.
58. Wieman, H. L.; Wofford, J. A.; Rathmell, J. C. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. Mol. Biol. Cell 2007, 18 (4), 1437-1446.
59. Drozdowski, L. A.; Thomson, A. B. R. Intestinal sugar transport. World J. Gastroenterol. 2006, 12 (11), 1657-1670.
60. Edinger, A. L. Controlling cell growth and survival through regulated nutrient transporter expression. Biochem. J. 2007, 406 (1), 1-12.
61. Gamper, N.; Shapiro, M. S. Regulation of ion transport proteins by membrane phosphoinositides. Nat. Rev. Neurosci. 2007, 8 (12), 921-934.
62. Seroussi, E.; Pan, H. Q.; Kedra, D.; Roe, B. A.; Dumanski, J. P. Characterization of the human NIPSNAP1 gene from 22q12: a member of a novel gene family. Gene 1998, 212 (1), 13-20.
63. Sorensen, J. B. SNARE complexes prepare for membrane fusion. Trends Neurosci. 2005, 28 (9), 453-455.
64. Heo, W. D.; Inoue, T.; Park, W. S.; Kim, M. L.; Park, B. O.; Wandless, T. J.; Meyer, T. PI(3,4,5)P3 and PI(4,5)P2 lipids target proteins with polybasic clusters to the plasma membrane. Science 2006, 314 (5804), 1458-1461.
65. Deane, J. A.; Fruman, D. A. Phosphoinositide 3-kinase: Diverse roles in immune cell activation. Annu. Rev. Immunol. 2004, 22, 563-598.
66. Jiang, K.; Sun, J.; Cheng, J.; Djeu, J. Y.; Wei, S.; Sebti, S. Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis. Mol. Cell. Biol. 2004, 24 (12), 5565-5576.
67. Bodemann, B. O.; White, M. A. Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat. Rev. Cancer 2008, 8 (2), 133-140.
68. Wennerberg, K.; Rossman, K. L.; Der, C. J. The Ras superfamily at a glance. J. Cell Sci. 2005, 118 (5), 843-846.
69. Stöckli, J.; Davey, J. R.; Hohnen-Behrens, C.; Xu, A.; James, D. E.; Ramm, G. Regulation of Glucose Transporter 4 Translocation by the Rab Guanosine Triphosphatase-Activating Protein AS160/TBC1D4: Role of Phosphorylation and Membrane Association. Mol. Endocrinol. 2008, 22 (12), 2703.
70. Schmidt, A.; Durgan, J.; Magalhaes, A.; Hall, A. Rho GTPases regulate PRK2/PKN2 to control entry into mitosis and exit from cytokinesis. EMBO J. 2007, 26 (6), 1624-1636.
71. Balendran, A.; Biondi, R. M.; Cheung, P. C. F.; Casamayor, A.; Deak, M.; Alessi, D. R. A 3-phosphoinositide-dependent protein kinase-1 (PDK1) docking site is required for the phosphorylation of protein kinase C zeta (PKC zeta) and PKC-related kinase 2 by PDK1. J. Biol. Chem. 2000, 275 (27), 20806-20813.
72. Balendran, A.; Casamayor, A.; Deak, M.; Paterson, A.; Gaffney, P.; Currie, R.; Downes, C. P.; Alessi, D. R. PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr. Biol. 1999, 9 (8), 393-404.
73. Mukai, H. The structure and function of PKN, a protein kinase having a catalytic domain homologous to that of PKC. J. Biochem 2003, 133 (1), 17-27.
74. Koh, H.; Lee, K. H.; Kim, D.; Kim, S.; Kim, J. W.; Chung, J. Inhibition of Akt and its anti-apoptotic activities by tumor necrosis factor-induced protein kinase C-related kinase 2 (PRK2) cleavage. J. Biol. Chem. 2000, 275 (44), 34451-34458.
75. Pang, J. H.; Kraemer, A.; Stehbens, S. J.; Frame, M. C.; Yap, A. S. Recruitment of phosphoinositide 3-kinase defines a positive contribution of tyrosine kinase signaling to E-cadherin function. J. Biol. Chem. 2005, 280 (4), 3043-3050.
76. Woodfield, R. J.; Hodgkin, M. N.; Akhtar, N.; Morse, M. A.; Fuller, K. J.; Saqib, K.; Thompson, N. T.; Wakelam, M. J. O. The p85 subunit of phosphoinositide 3-kinase is associated with beta-catenin in the cadherin-based adhesion complex. Biochem. J. 2001, 360 (2), 335-344.
77. Espada, J.; Perez-Moreno, M.; Braga, V. M. M.; Rodriguez-Viciana, P.; Cano, A. H-Ras activation promotes cytoplasmic accumulation and phosphoinositide 3-OH kinase association of beta-catenin in epidermal keratinocytes. J. Cell Biol. 1999, 146 (5), 967-980.
78. Alahari, S. K.; Reddig, P. J.; Juliano, R. L. Biological aspects of signal transduction by cell adhesion receptors. Int. Rev. Cytol. 2002, 220, 145-184.
79. Cosemans, J. M. E. M.; Iserbyt, B. F.; Deckmyn, H.; Heemskerk, J. W. M. Multiple ways to switch platelet integrins on and off. J. Thromb. Haemost. 2008, 6 (8), 1253-1261.
80. Liu, F. T.; Rabinovich, G. A. Galectins as modulators of tumour progression. Nat. Rev. Cancer 2005, 5 (1), 29-41.
81. Jin, Y. P.; Fishbein, M. C.; Said, J. W.; Jindra, P. T.; Rajalingam, R.; Rozengurt, E.; Reed, E. F. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Hum. Immunol. 2004, 65 (4), 291-302.
82. Narayan, K.; Lemmon, M. A. Determining selectivity of phosphoinositide-binding domains. Methods 2006, 39 (2), 122-133.
83. Zhang, H.-H.; Walker, F.; Kiflemariam, S.; Whitehead, R. H.; Williams, D.; Phillips, W. A.; Dobrovic, A.; Burgess, A. W. Selective inhibition of proliferation in colorectal carcinoma cell lines expressing mutant APC or activated B-Raf. Int. J. Cancer 2009, In press.